Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant.
about
Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitantPreparation and pharmacokinetic study of aprepitant-sulfobutyl ether-β-cyclodextrin complex.Involvement of substance P and the NK-1 receptor in pancreatic cancer.Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.Has nanotechnology led to improved therapeutic outcomes?Safety of neurokinin-1 receptor antagonists.Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy.Hot melt extruded Aprepitant-Soluplus solid dispersion: preformulation considerations, stability and in vitro study.
P2860
Q36823546-B3FF31BD-1112-4215-90F6-17CD9C496087Q37538937-B4F12B4C-67C8-4E43-A7CD-0D2AFEFA4D49Q37617971-19D92928-29EE-43D3-868A-59DD9EDA3977Q37857329-E4C0B1CD-7FF9-4926-AFCB-CEFB28EED0DEQ37970730-A634F1FB-5043-4742-B064-391B40B1F59CQ38109245-55A4A36E-7170-4F42-B4B9-4757B9C989C2Q39275766-A578C0DF-0C3D-49AC-A986-783ADC398422Q48062570-06FD8045-F114-4A59-BC85-0E227BDF5DF5
P2860
Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant.
@en
type
label
Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant.
@en
prefLabel
Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant.
@en
P2093
P2860
P356
P1476
Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant.
@en
P2093
Karen C Thompson
Suhas Shelukar
P2860
P356
10.2147/NANO.2007.2.1.13
P407
P577
2007-01-01T00:00:00Z